Clinical Trial Update: A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 study comparing the adhesiveness of two rotigotine transdermal patches for Parkinson's disease has completed. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Neupro (rotigotine)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED | Results posted: 2015-11-02